Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Otvos

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Current Atherosclerosis Reports|August 7, 2004
Low-density lipoprotein particle number and risk for cardiovascular diseaseWilliam C Cromwell, James D Otvos
The American Journal of Cardiology|December 6, 2006
Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dlWilliam C Cromwell, James D Otvos
Translational Research : the Journal of Laboratory and Clinical Medicine|February 7, 2016
High-density lipoprotein and inflammation in cardiovascular diseaseMargery A Connelly, Irina Shalaurova, James D Otvos
Diabetes Care|March 7, 2009
Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled studyRobert S Rosenson, James D Otvos, Judith Hsia
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2004
Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse modelsKe Ma, Trudy Forte, James D Otvos, et al.
The American Journal of Cardiology|November 7, 2002
Measurement issues related to lipoprotein heterogeneityJames D Otvos, Elias J Jeyarajah, William C Cromwell
Clinics in Laboratory Medicine|November 18, 2006
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopyElias J Jeyarajah, William C Cromwell, James D Otvos
The American Journal of Cardiology|July 11, 2002
Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trialRobert S Rosenson, James D Otvos, David S Freedman
Clinical Biochemistry|April 29, 2014
Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjectsRobin P F Dullaart, James D Otvos, Richard W James
Atherosclerosis|November 30, 2005
Treatment of obesity with diet/exercise versus pioglitazone has distinct effects on lipoprotein particle sizeSamyah Shadid, Ralph LaForge, James D Otvos, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Current Atherosclerosis Reports|August 7, 2004
Low-density lipoprotein particle number and risk for cardiovascular diseaseWilliam C Cromwell, James D Otvos
The American Journal of Cardiology|December 6, 2006
Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dlWilliam C Cromwell, James D Otvos
Translational Research : the Journal of Laboratory and Clinical Medicine|February 7, 2016
High-density lipoprotein and inflammation in cardiovascular diseaseMargery A Connelly, Irina Shalaurova, James D Otvos
Diabetes Care|March 7, 2009
Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled studyRobert S Rosenson, James D Otvos, Judith Hsia
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2004
Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse modelsKe Ma, Trudy Forte, James D Otvos, et al.
The American Journal of Cardiology|November 7, 2002
Measurement issues related to lipoprotein heterogeneityJames D Otvos, Elias J Jeyarajah, William C Cromwell
Clinics in Laboratory Medicine|November 18, 2006
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopyElias J Jeyarajah, William C Cromwell, James D Otvos
The American Journal of Cardiology|July 11, 2002
Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trialRobert S Rosenson, James D Otvos, David S Freedman
Clinical Biochemistry|April 29, 2014
Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjectsRobin P F Dullaart, James D Otvos, Richard W James
Atherosclerosis|November 30, 2005
Treatment of obesity with diet/exercise versus pioglitazone has distinct effects on lipoprotein particle sizeSamyah Shadid, Ralph LaForge, James D Otvos, et al.
Pageof 15